nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—Mitomycin—urinary bladder cancer	0.153	0.297	CbGbCtD
Telaprevir—ALB—Fluorouracil—urinary bladder cancer	0.0722	0.14	CbGbCtD
Telaprevir—CYP3A4—Thiotepa—urinary bladder cancer	0.0697	0.135	CbGbCtD
Telaprevir—ABCB1—Gemcitabine—urinary bladder cancer	0.0442	0.0854	CbGbCtD
Telaprevir—ALB—Methotrexate—urinary bladder cancer	0.0398	0.077	CbGbCtD
Telaprevir—ABCB1—Cisplatin—urinary bladder cancer	0.0321	0.0621	CbGbCtD
Telaprevir—ABCB1—Etoposide—urinary bladder cancer	0.0315	0.061	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—urinary bladder cancer	0.0215	0.0416	CbGbCtD
Telaprevir—ABCB1—Methotrexate—urinary bladder cancer	0.0208	0.0403	CbGbCtD
Telaprevir—CYP3A4—Etoposide—urinary bladder cancer	0.0189	0.0365	CbGbCtD
Telaprevir—CMA1—prostate gland—urinary bladder cancer	0.0135	0.093	CbGeAlD
Telaprevir—CYP3A4—Doxorubicin—urinary bladder cancer	0.0129	0.0249	CbGbCtD
Telaprevir—CMA1—smooth muscle tissue—urinary bladder cancer	0.00957	0.0659	CbGeAlD
Telaprevir—CTSK—prostate gland—urinary bladder cancer	0.00871	0.0599	CbGeAlD
Telaprevir—CTSS—prostate gland—urinary bladder cancer	0.00763	0.0525	CbGeAlD
Telaprevir—CMA1—female reproductive system—urinary bladder cancer	0.00737	0.0508	CbGeAlD
Telaprevir—CTSK—seminal vesicle—urinary bladder cancer	0.00736	0.0507	CbGeAlD
Telaprevir—CTSS—seminal vesicle—urinary bladder cancer	0.00645	0.0444	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—urinary bladder cancer	0.00616	0.0424	CbGeAlD
Telaprevir—CTSK—renal system—urinary bladder cancer	0.00593	0.0409	CbGeAlD
Telaprevir—CTSK—urethra—urinary bladder cancer	0.00583	0.0401	CbGeAlD
Telaprevir—CTSS—smooth muscle tissue—urinary bladder cancer	0.0054	0.0372	CbGeAlD
Telaprevir—CYP3A4—urine—urinary bladder cancer	0.0053	0.0365	CbGeAlD
Telaprevir—CTSS—renal system—urinary bladder cancer	0.0052	0.0358	CbGeAlD
Telaprevir—CTSS—urethra—urinary bladder cancer	0.00511	0.0352	CbGeAlD
Telaprevir—CTSK—female reproductive system—urinary bladder cancer	0.00475	0.0327	CbGeAlD
Telaprevir—ORM1—prostate gland—urinary bladder cancer	0.00455	0.0314	CbGeAlD
Telaprevir—CMA1—lymph node—urinary bladder cancer	0.00431	0.0297	CbGeAlD
Telaprevir—CTSK—vagina—urinary bladder cancer	0.0043	0.0296	CbGeAlD
Telaprevir—CTSS—female reproductive system—urinary bladder cancer	0.00416	0.0287	CbGeAlD
Telaprevir—CTSS—vagina—urinary bladder cancer	0.00377	0.0259	CbGeAlD
Telaprevir—CTSK—lymph node—urinary bladder cancer	0.00278	0.0191	CbGeAlD
Telaprevir—ORM1—female reproductive system—urinary bladder cancer	0.00249	0.0171	CbGeAlD
Telaprevir—CTSS—lymph node—urinary bladder cancer	0.00244	0.0168	CbGeAlD
Telaprevir—ORM1—lymph node—urinary bladder cancer	0.00145	0.01	CbGeAlD
Telaprevir—Diarrhoea—Valrubicin—urinary bladder cancer	0.00136	0.0062	CcSEcCtD
Telaprevir—Shock—Mitomycin—urinary bladder cancer	0.00135	0.00614	CcSEcCtD
Telaprevir—ABCB1—prostate gland—urinary bladder cancer	0.00135	0.00927	CbGeAlD
Telaprevir—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00134	0.00611	CcSEcCtD
Telaprevir—Candida infection—Etoposide—urinary bladder cancer	0.00132	0.00604	CcSEcCtD
Telaprevir—Anorectal discomfort—Doxorubicin—urinary bladder cancer	0.00132	0.006	CcSEcCtD
Telaprevir—Dizziness—Valrubicin—urinary bladder cancer	0.00132	0.00599	CcSEcCtD
Telaprevir—Blood creatinine increased—Thiotepa—urinary bladder cancer	0.00131	0.00599	CcSEcCtD
Telaprevir—CYP3A4—renal system—urinary bladder cancer	0.0013	0.00892	CbGeAlD
Telaprevir—ALB—lymph node—urinary bladder cancer	0.00128	0.00878	CbGeAlD
Telaprevir—Vomiting—Valrubicin—urinary bladder cancer	0.00126	0.00576	CcSEcCtD
Telaprevir—Rash—Valrubicin—urinary bladder cancer	0.00125	0.00572	CcSEcCtD
Telaprevir—Dermatitis—Valrubicin—urinary bladder cancer	0.00125	0.00571	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—urinary bladder cancer	0.00122	0.00558	CcSEcCtD
Telaprevir—Renal failure acute—Cisplatin—urinary bladder cancer	0.00119	0.00543	CcSEcCtD
Telaprevir—Nausea—Valrubicin—urinary bladder cancer	0.00118	0.00538	CcSEcCtD
Telaprevir—Fatigue—Mitomycin—urinary bladder cancer	0.00118	0.00538	CcSEcCtD
Telaprevir—ABCB1—seminal vesicle—urinary bladder cancer	0.00114	0.00784	CbGeAlD
Telaprevir—Oral candidiasis—Doxorubicin—urinary bladder cancer	0.00113	0.00516	CcSEcCtD
Telaprevir—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.00111	0.00504	CcSEcCtD
Telaprevir—Infestation—Thiotepa—urinary bladder cancer	0.00108	0.00492	CcSEcCtD
Telaprevir—Infestation NOS—Thiotepa—urinary bladder cancer	0.00108	0.00492	CcSEcCtD
Telaprevir—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00107	0.00489	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.00106	0.00484	CcSEcCtD
Telaprevir—CYP3A4—female reproductive system—urinary bladder cancer	0.00104	0.00714	CbGeAlD
Telaprevir—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.00103	0.00469	CcSEcCtD
Telaprevir—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00102	0.00466	CcSEcCtD
Telaprevir—Hypokalaemia—Cisplatin—urinary bladder cancer	0.001	0.00456	CcSEcCtD
Telaprevir—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000993	0.00452	CcSEcCtD
Telaprevir—ABCB1—epithelium—urinary bladder cancer	0.000989	0.00681	CbGeAlD
Telaprevir—Asthenia—Mitomycin—urinary bladder cancer	0.000983	0.00448	CcSEcCtD
Telaprevir—Urinary tract disorder—Thiotepa—urinary bladder cancer	0.000958	0.00437	CcSEcCtD
Telaprevir—Urethral disorder—Thiotepa—urinary bladder cancer	0.000951	0.00433	CcSEcCtD
Telaprevir—Diarrhoea—Mitomycin—urinary bladder cancer	0.000938	0.00427	CcSEcCtD
Telaprevir—ABCB1—renal system—urinary bladder cancer	0.000917	0.00631	CbGeAlD
Telaprevir—Hyperbilirubinaemia—Methotrexate—urinary bladder cancer	0.000914	0.00417	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.000907	0.00413	CcSEcCtD
Telaprevir—Eye disorder—Thiotepa—urinary bladder cancer	0.000907	0.00413	CcSEcCtD
Telaprevir—Dizziness—Mitomycin—urinary bladder cancer	0.000906	0.00413	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000901	0.00411	CcSEcCtD
Telaprevir—ABCB1—urethra—urinary bladder cancer	0.000901	0.0062	CbGeAlD
Telaprevir—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.000896	0.00408	CcSEcCtD
Telaprevir—Infestation NOS—Fluorouracil—urinary bladder cancer	0.000894	0.00407	CcSEcCtD
Telaprevir—Infestation—Fluorouracil—urinary bladder cancer	0.000894	0.00407	CcSEcCtD
Telaprevir—Vomiting—Mitomycin—urinary bladder cancer	0.000871	0.00397	CcSEcCtD
Telaprevir—Rash—Mitomycin—urinary bladder cancer	0.000864	0.00394	CcSEcCtD
Telaprevir—Dermatitis—Mitomycin—urinary bladder cancer	0.000863	0.00393	CcSEcCtD
Telaprevir—Rectal haemorrhage—Epirubicin—urinary bladder cancer	0.000861	0.00392	CcSEcCtD
Telaprevir—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00086	0.00392	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—urinary bladder cancer	0.000855	0.0039	CcSEcCtD
Telaprevir—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.000846	0.00386	CcSEcCtD
Telaprevir—Malnutrition—Thiotepa—urinary bladder cancer	0.000844	0.00385	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.000839	0.00382	CcSEcCtD
Telaprevir—Nausea—Mitomycin—urinary bladder cancer	0.000814	0.00371	CcSEcCtD
Telaprevir—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.000806	0.00367	CcSEcCtD
Telaprevir—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.000804	0.00366	CcSEcCtD
Telaprevir—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000801	0.00365	CcSEcCtD
Telaprevir—Urethral disorder—Gemcitabine—urinary bladder cancer	0.0008	0.00365	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—urinary bladder cancer	0.000797	0.00363	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.000792	0.00361	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—urinary bladder cancer	0.000791	0.00361	CcSEcCtD
Telaprevir—Anaemia—Thiotepa—urinary bladder cancer	0.000781	0.00356	CcSEcCtD
Telaprevir—Infestation—Etoposide—urinary bladder cancer	0.000776	0.00354	CcSEcCtD
Telaprevir—Infestation NOS—Etoposide—urinary bladder cancer	0.000776	0.00354	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.000776	0.00354	CcSEcCtD
Telaprevir—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000772	0.00352	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00077	0.00351	CcSEcCtD
Telaprevir—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.000751	0.00342	CcSEcCtD
Telaprevir—Urethral disorder—Cisplatin—urinary bladder cancer	0.000746	0.0034	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—urinary bladder cancer	0.000743	0.00338	CcSEcCtD
Telaprevir—ABCB1—female reproductive system—urinary bladder cancer	0.000735	0.00506	CbGeAlD
Telaprevir—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000734	0.00335	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.000733	0.00334	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000714	0.00325	CcSEcCtD
Telaprevir—Eye disorder—Cisplatin—urinary bladder cancer	0.000711	0.00324	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—urinary bladder cancer	0.000688	0.00314	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—urinary bladder cancer	0.000687	0.00313	CcSEcCtD
Telaprevir—Infection—Thiotepa—urinary bladder cancer	0.000685	0.00312	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—urinary bladder cancer	0.000683	0.00311	CcSEcCtD
Telaprevir—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000676	0.00308	CcSEcCtD
Telaprevir—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000675	0.00308	CcSEcCtD
Telaprevir—Skin disorder—Thiotepa—urinary bladder cancer	0.000669	0.00305	CcSEcCtD
Telaprevir—ABCB1—vagina—urinary bladder cancer	0.000664	0.00457	CbGeAlD
Telaprevir—Malnutrition—Cisplatin—urinary bladder cancer	0.000662	0.00302	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—urinary bladder cancer	0.000659	0.003	CcSEcCtD
Telaprevir—Anaemia—Gemcitabine—urinary bladder cancer	0.000657	0.00299	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—urinary bladder cancer	0.000654	0.00298	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—urinary bladder cancer	0.000651	0.00297	CcSEcCtD
Telaprevir—Anaemia—Fluorouracil—urinary bladder cancer	0.000646	0.00294	CcSEcCtD
Telaprevir—Eczema—Epirubicin—urinary bladder cancer	0.000628	0.00286	CcSEcCtD
Telaprevir—Anaemia—Cisplatin—urinary bladder cancer	0.000612	0.00279	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—urinary bladder cancer	0.000612	0.00279	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000601	0.00274	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000595	0.00271	CcSEcCtD
Telaprevir—Fatigue—Thiotepa—urinary bladder cancer	0.000594	0.00271	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—urinary bladder cancer	0.000594	0.00271	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—urinary bladder cancer	0.000581	0.00265	CcSEcCtD
Telaprevir—Infection—Gemcitabine—urinary bladder cancer	0.000576	0.00262	CcSEcCtD
Telaprevir—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000569	0.00259	CcSEcCtD
Telaprevir—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000568	0.00259	CcSEcCtD
Telaprevir—Infection—Fluorouracil—urinary bladder cancer	0.000566	0.00258	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000566	0.00258	CcSEcCtD
Telaprevir—Skin disorder—Gemcitabine—urinary bladder cancer	0.000563	0.00257	CcSEcCtD
Telaprevir—Anaemia—Etoposide—urinary bladder cancer	0.000561	0.00255	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00056	0.00255	CcSEcCtD
Telaprevir—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000559	0.00255	CcSEcCtD
Telaprevir—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000558	0.00254	CcSEcCtD
Telaprevir—Urticaria—Thiotepa—urinary bladder cancer	0.000548	0.0025	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000543	0.00248	CcSEcCtD
Telaprevir—Infection—Cisplatin—urinary bladder cancer	0.000537	0.00245	CcSEcCtD
Telaprevir—Loss of consciousness—Etoposide—urinary bladder cancer	0.000533	0.00243	CcSEcCtD
Telaprevir—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00053	0.00242	CcSEcCtD
Telaprevir—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000529	0.00241	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000529	0.00241	CcSEcCtD
Telaprevir—Skin disorder—Cisplatin—urinary bladder cancer	0.000525	0.00239	CcSEcCtD
Telaprevir—Eosinophilia—Methotrexate—urinary bladder cancer	0.000516	0.00235	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000514	0.00234	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000513	0.00234	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000508	0.00232	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000501	0.00228	CcSEcCtD
Telaprevir—Fatigue—Gemcitabine—urinary bladder cancer	0.0005	0.00228	CcSEcCtD
Telaprevir—Asthenia—Thiotepa—urinary bladder cancer	0.000494	0.00225	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000492	0.00224	CcSEcCtD
Telaprevir—Infection—Etoposide—urinary bladder cancer	0.000492	0.00224	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000489	0.00223	CcSEcCtD
Telaprevir—Pruritus—Thiotepa—urinary bladder cancer	0.000488	0.00222	CcSEcCtD
Telaprevir—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000485	0.00221	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—urinary bladder cancer	0.000483	0.0022	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—urinary bladder cancer	0.000481	0.00219	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000475	0.00217	CcSEcCtD
Telaprevir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000472	0.00215	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00047	0.00214	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000467	0.00213	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—urinary bladder cancer	0.000465	0.00212	CcSEcCtD
Telaprevir—Infestation—Methotrexate—urinary bladder cancer	0.000465	0.00212	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000461	0.0021	CcSEcCtD
Telaprevir—Dizziness—Thiotepa—urinary bladder cancer	0.000456	0.00208	CcSEcCtD
Telaprevir—Urticaria—Fluorouracil—urinary bladder cancer	0.000453	0.00206	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000447	0.00204	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00044	0.002	CcSEcCtD
Telaprevir—Vomiting—Thiotepa—urinary bladder cancer	0.000438	0.002	CcSEcCtD
Telaprevir—Infestation—Epirubicin—urinary bladder cancer	0.000435	0.00198	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—urinary bladder cancer	0.000435	0.00198	CcSEcCtD
Telaprevir—Rash—Thiotepa—urinary bladder cancer	0.000435	0.00198	CcSEcCtD
Telaprevir—Dermatitis—Thiotepa—urinary bladder cancer	0.000434	0.00198	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000431	0.00197	CcSEcCtD
Telaprevir—ABCB1—lymph node—urinary bladder cancer	0.00043	0.00296	CbGeAlD
Telaprevir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000427	0.00195	CcSEcCtD
Telaprevir—Fatigue—Etoposide—urinary bladder cancer	0.000427	0.00195	CcSEcCtD
Telaprevir—Asthenia—Gemcitabine—urinary bladder cancer	0.000416	0.0019	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000412	0.00188	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000412	0.00188	CcSEcCtD
Telaprevir—Pruritus—Gemcitabine—urinary bladder cancer	0.00041	0.00187	CcSEcCtD
Telaprevir—Nausea—Thiotepa—urinary bladder cancer	0.000409	0.00187	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—urinary bladder cancer	0.000409	0.00186	CcSEcCtD
Telaprevir—Pruritus—Fluorouracil—urinary bladder cancer	0.000403	0.00184	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—urinary bladder cancer	0.000403	0.00183	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000403	0.00183	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000399	0.00182	CcSEcCtD
Telaprevir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000397	0.00181	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000395	0.0018	CcSEcCtD
Telaprevir—Urticaria—Etoposide—urinary bladder cancer	0.000393	0.00179	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—urinary bladder cancer	0.00039	0.00178	CcSEcCtD
Telaprevir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00039	0.00178	CcSEcCtD
Telaprevir—Asthenia—Cisplatin—urinary bladder cancer	0.000388	0.00177	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000386	0.00176	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000385	0.00175	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000383	0.00174	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000381	0.00174	CcSEcCtD
Telaprevir—Dizziness—Fluorouracil—urinary bladder cancer	0.000377	0.00172	CcSEcCtD
Telaprevir—Diarrhoea—Cisplatin—urinary bladder cancer	0.00037	0.00168	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000369	0.00168	CcSEcCtD
Telaprevir—Vomiting—Gemcitabine—urinary bladder cancer	0.000369	0.00168	CcSEcCtD
Telaprevir—Rash—Gemcitabine—urinary bladder cancer	0.000366	0.00167	CcSEcCtD
Telaprevir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000365	0.00166	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—urinary bladder cancer	0.000365	0.00166	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—urinary bladder cancer	0.000363	0.00166	CcSEcCtD
Telaprevir—Vomiting—Fluorouracil—urinary bladder cancer	0.000362	0.00165	CcSEcCtD
Telaprevir—Rash—Fluorouracil—urinary bladder cancer	0.000359	0.00164	CcSEcCtD
Telaprevir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000359	0.00164	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000357	0.00163	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000356	0.00162	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—urinary bladder cancer	0.000356	0.00162	CcSEcCtD
Telaprevir—Asthenia—Etoposide—urinary bladder cancer	0.000355	0.00162	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000354	0.00161	CcSEcCtD
Telaprevir—Pruritus—Etoposide—urinary bladder cancer	0.00035	0.0016	CcSEcCtD
Telaprevir—Nausea—Gemcitabine—urinary bladder cancer	0.000344	0.00157	CcSEcCtD
Telaprevir—Vomiting—Cisplatin—urinary bladder cancer	0.000344	0.00157	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000342	0.00156	CcSEcCtD
Telaprevir—Rash—Cisplatin—urinary bladder cancer	0.000341	0.00155	CcSEcCtD
Telaprevir—Dermatitis—Cisplatin—urinary bladder cancer	0.00034	0.00155	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—urinary bladder cancer	0.00034	0.00155	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—urinary bladder cancer	0.000339	0.00154	CcSEcCtD
Telaprevir—Nausea—Fluorouracil—urinary bladder cancer	0.000339	0.00154	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—urinary bladder cancer	0.000338	0.00154	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—urinary bladder cancer	0.000336	0.00153	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—urinary bladder cancer	0.000333	0.00152	CcSEcCtD
Telaprevir—Dizziness—Etoposide—urinary bladder cancer	0.000327	0.00149	CcSEcCtD
Telaprevir—Nausea—Cisplatin—urinary bladder cancer	0.000321	0.00146	CcSEcCtD
Telaprevir—Vomiting—Etoposide—urinary bladder cancer	0.000315	0.00143	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000315	0.00143	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—urinary bladder cancer	0.000314	0.00143	CcSEcCtD
Telaprevir—Rash—Etoposide—urinary bladder cancer	0.000312	0.00142	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—urinary bladder cancer	0.000312	0.00142	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000308	0.0014	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000307	0.0014	CcSEcCtD
Telaprevir—Syncope—Epirubicin—urinary bladder cancer	0.000305	0.00139	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000299	0.00136	CcSEcCtD
Telaprevir—Infection—Methotrexate—urinary bladder cancer	0.000295	0.00134	CcSEcCtD
Telaprevir—Nausea—Etoposide—urinary bladder cancer	0.000294	0.00134	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000291	0.00133	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—urinary bladder cancer	0.000291	0.00133	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00029	0.00132	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—urinary bladder cancer	0.000288	0.00131	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000287	0.00131	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—urinary bladder cancer	0.000282	0.00129	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000277	0.00126	CcSEcCtD
Telaprevir—Infection—Epirubicin—urinary bladder cancer	0.000276	0.00126	CcSEcCtD
Telaprevir—Shock—Epirubicin—urinary bladder cancer	0.000273	0.00124	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000272	0.00124	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000272	0.00124	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—urinary bladder cancer	0.00027	0.00123	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000266	0.00121	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000256	0.00117	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—urinary bladder cancer	0.000256	0.00117	CcSEcCtD
Telaprevir—Infection—Doxorubicin—urinary bladder cancer	0.000255	0.00116	CcSEcCtD
Telaprevir—Shock—Doxorubicin—urinary bladder cancer	0.000253	0.00115	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000252	0.00115	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000251	0.00115	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000249	0.00114	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00024	0.00109	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—urinary bladder cancer	0.000239	0.00109	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—urinary bladder cancer	0.000236	0.00107	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000222	0.00101	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—urinary bladder cancer	0.000221	0.00101	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—urinary bladder cancer	0.00022	0.001	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—urinary bladder cancer	0.000213	0.00097	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—urinary bladder cancer	0.00021	0.000956	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—urinary bladder cancer	0.000204	0.00093	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000203	0.000925	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—urinary bladder cancer	0.000199	0.000907	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000197	0.00166	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR3—urinary bladder cancer	0.000197	0.00166	CbGpPWpGaD
Telaprevir—Pruritus—Epirubicin—urinary bladder cancer	0.000196	0.000895	CcSEcCtD
Telaprevir—Dizziness—Methotrexate—urinary bladder cancer	0.000196	0.000894	CcSEcCtD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000195	0.00165	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDH1—urinary bladder cancer	0.000194	0.00164	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RBX1—urinary bladder cancer	0.000191	0.00162	CbGpPWpGaD
Telaprevir—CTSK—Immune System—S100B—urinary bladder cancer	0.000191	0.00162	CbGpPWpGaD
Telaprevir—Diarrhoea—Epirubicin—urinary bladder cancer	0.00019	0.000865	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—FGFR3—urinary bladder cancer	0.000189	0.0016	CbGpPWpGaD
Telaprevir—Vomiting—Methotrexate—urinary bladder cancer	0.000189	0.000859	CcSEcCtD
Telaprevir—Rash—Methotrexate—urinary bladder cancer	0.000187	0.000852	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—urinary bladder cancer	0.000187	0.000851	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—urinary bladder cancer	0.000184	0.00084	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—urinary bladder cancer	0.000184	0.000836	CcSEcCtD
Telaprevir—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000182	0.00154	CbGpPWpGaD
Telaprevir—Pruritus—Doxorubicin—urinary bladder cancer	0.000182	0.000828	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—TSC1—urinary bladder cancer	0.00018	0.00152	CbGpPWpGaD
Telaprevir—Vomiting—Epirubicin—urinary bladder cancer	0.000176	0.000804	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000176	0.00149	CbGpPWpGaD
Telaprevir—Nausea—Methotrexate—urinary bladder cancer	0.000176	0.000803	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000176	0.000801	CcSEcCtD
Telaprevir—Rash—Epirubicin—urinary bladder cancer	0.000175	0.000797	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—urinary bladder cancer	0.000175	0.000797	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—JAG1—urinary bladder cancer	0.000171	0.00145	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00017	0.00144	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—urinary bladder cancer	0.00017	0.00144	CbGpPWpGaD
Telaprevir—Dizziness—Doxorubicin—urinary bladder cancer	0.00017	0.000774	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—CREBBP—urinary bladder cancer	0.000167	0.00141	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IFNA2—urinary bladder cancer	0.000167	0.00141	CbGpPWpGaD
Telaprevir—Nausea—Epirubicin—urinary bladder cancer	0.000165	0.000751	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—urinary bladder cancer	0.000163	0.00138	CbGpPWpGaD
Telaprevir—Vomiting—Doxorubicin—urinary bladder cancer	0.000163	0.000744	CcSEcCtD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000163	0.00137	CbGpPWpGaD
Telaprevir—Rash—Doxorubicin—urinary bladder cancer	0.000162	0.000738	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000162	0.000737	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—CDH1—urinary bladder cancer	0.00016	0.00135	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000158	0.00134	CbGpPWpGaD
Telaprevir—CTSS—Immune System—S100B—urinary bladder cancer	0.000157	0.00133	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000157	0.00133	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000156	0.00132	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000156	0.00132	CbGpPWpGaD
Telaprevir—Nausea—Doxorubicin—urinary bladder cancer	0.000153	0.000695	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000151	0.00128	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CDKN1A—urinary bladder cancer	0.000145	0.00123	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PTEN—urinary bladder cancer	0.000145	0.00123	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000144	0.00122	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000142	0.0012	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000141	0.00119	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—urinary bladder cancer	0.00014	0.00118	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.00014	0.00118	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PTEN—urinary bladder cancer	0.000139	0.00118	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR3—urinary bladder cancer	0.000139	0.00118	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—S100B—urinary bladder cancer	0.000139	0.00117	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EP300—urinary bladder cancer	0.000138	0.00117	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000135	0.00114	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—SRC—urinary bladder cancer	0.000135	0.00114	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—urinary bladder cancer	0.000135	0.00114	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000132	0.00111	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00013	0.0011	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SRC—urinary bladder cancer	0.000129	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000126	0.00106	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000125	0.00105	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000121	0.00102	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CDKN1A—urinary bladder cancer	0.00012	0.00101	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PTEN—urinary bladder cancer	0.00012	0.00101	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CREBBP—urinary bladder cancer	0.000118	0.001	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—urinary bladder cancer	0.000118	0.000997	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000118	0.000995	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—urinary bladder cancer	0.000118	0.000993	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000117	0.000993	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000116	0.000981	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.000115	0.000972	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTEN—urinary bladder cancer	0.000115	0.00097	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR3—urinary bladder cancer	0.000115	0.000968	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EP300—urinary bladder cancer	0.000114	0.000964	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—urinary bladder cancer	0.000113	0.000958	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—urinary bladder cancer	0.000111	0.000942	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—SRC—urinary bladder cancer	0.000111	0.000937	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TERT—urinary bladder cancer	0.00011	0.000929	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000108	0.000909	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—urinary bladder cancer	0.000107	0.000905	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000106	0.0009	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SRC—urinary bladder cancer	0.000106	0.0009	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000105	0.00089	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000103	0.00087	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000103	0.000869	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000102	0.000863	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR3—urinary bladder cancer	0.000101	0.000853	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.0001	0.000845	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—urinary bladder cancer	9.91e-05	0.000838	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—urinary bladder cancer	9.86e-05	0.000834	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.82e-05	0.00083	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ESR1—urinary bladder cancer	9.8e-05	0.000828	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CREBBP—urinary bladder cancer	9.75e-05	0.000824	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—urinary bladder cancer	9.72e-05	0.000821	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—urinary bladder cancer	9.68e-05	0.000818	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.58e-05	0.00081	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—urinary bladder cancer	9.47e-05	0.000801	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—urinary bladder cancer	9.33e-05	0.000789	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—urinary bladder cancer	9.18e-05	0.000776	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—urinary bladder cancer	9.1e-05	0.000769	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—urinary bladder cancer	8.99e-05	0.000759	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—urinary bladder cancer	8.81e-05	0.000745	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.7e-05	0.000735	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—urinary bladder cancer	8.7e-05	0.000735	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CREBBP—urinary bladder cancer	8.59e-05	0.000726	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IGF1—urinary bladder cancer	8.48e-05	0.000717	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1A—urinary bladder cancer	8.47e-05	0.000716	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTEN—urinary bladder cancer	8.45e-05	0.000715	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.39e-05	0.000709	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—urinary bladder cancer	8.16e-05	0.00069	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EP300—urinary bladder cancer	8.06e-05	0.000681	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTZ1—urinary bladder cancer	8.03e-05	0.000679	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SRC—urinary bladder cancer	7.84e-05	0.000663	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.84e-05	0.000662	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—urinary bladder cancer	7.8e-05	0.000659	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RHOA—urinary bladder cancer	7.77e-05	0.000657	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.69e-05	0.00065	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.66e-05	0.000647	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.62e-05	0.000644	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NAT1—urinary bladder cancer	7.61e-05	0.000643	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTO2—urinary bladder cancer	7.61e-05	0.000643	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—urinary bladder cancer	7.49e-05	0.000633	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.49e-05	0.000633	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	7.48e-05	0.000633	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—urinary bladder cancer	7.4e-05	0.000625	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—urinary bladder cancer	7.19e-05	0.000608	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.08e-05	0.000598	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.04e-05	0.000595	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1A—urinary bladder cancer	6.98e-05	0.00059	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.98e-05	0.00059	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—urinary bladder cancer	6.96e-05	0.000588	CbGpPWpGaD
Telaprevir—ALB—Metabolism—UGT2B7—urinary bladder cancer	6.96e-05	0.000588	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—urinary bladder cancer	6.87e-05	0.000581	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—urinary bladder cancer	6.82e-05	0.000576	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	6.7e-05	0.000566	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.68e-05	0.000565	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTO2—urinary bladder cancer	6.67e-05	0.000564	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NAT1—urinary bladder cancer	6.67e-05	0.000564	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EP300—urinary bladder cancer	6.64e-05	0.000561	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.6e-05	0.000558	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—urinary bladder cancer	6.52e-05	0.000551	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.5e-05	0.00055	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—urinary bladder cancer	6.49e-05	0.000549	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.47e-05	0.000547	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SRC—urinary bladder cancer	6.46e-05	0.000546	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.41e-05	0.000542	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—urinary bladder cancer	6.35e-05	0.000537	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP4B1—urinary bladder cancer	6.27e-05	0.00053	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—urinary bladder cancer	6.17e-05	0.000521	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.15e-05	0.00052	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	6.14e-05	0.000519	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—urinary bladder cancer	6.13e-05	0.000518	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.1e-05	0.000516	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA2—urinary bladder cancer	5.97e-05	0.000505	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC19A1—urinary bladder cancer	5.92e-05	0.0005	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—urinary bladder cancer	5.85e-05	0.000494	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PRSS3—urinary bladder cancer	5.77e-05	0.000488	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—urinary bladder cancer	5.69e-05	0.000481	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.67e-05	0.000479	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—urinary bladder cancer	5.66e-05	0.000478	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.6e-05	0.000473	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—urinary bladder cancer	5.52e-05	0.000466	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.49e-05	0.000464	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.47e-05	0.000462	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—urinary bladder cancer	5.35e-05	0.000452	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.19e-05	0.000438	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	5.15e-05	0.000435	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—urinary bladder cancer	5.1e-05	0.000431	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.05e-05	0.000427	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—urinary bladder cancer	4.99e-05	0.000421	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.94e-05	0.000418	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.78e-05	0.000404	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.77e-05	0.000403	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—urinary bladder cancer	4.71e-05	0.000398	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.63e-05	0.000391	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMP—urinary bladder cancer	4.61e-05	0.00039	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.55e-05	0.000385	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—urinary bladder cancer	4.54e-05	0.000384	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.49e-05	0.00038	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.43e-05	0.000374	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.42e-05	0.000374	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.33e-05	0.000366	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLAU—urinary bladder cancer	4.24e-05	0.000358	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—urinary bladder cancer	4.19e-05	0.000354	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NAT2—urinary bladder cancer	4.17e-05	0.000352	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.11e-05	0.000347	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.11e-05	0.000347	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.04e-05	0.000342	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—urinary bladder cancer	4e-05	0.000338	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.97e-05	0.000335	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.88e-05	0.000328	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.76e-05	0.000318	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.69e-05	0.000312	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.66e-05	0.00031	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.65e-05	0.000309	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RRM2—urinary bladder cancer	3.6e-05	0.000304	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CREBBP—urinary bladder cancer	3.5e-05	0.000296	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—urinary bladder cancer	3.45e-05	0.000292	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.38e-05	0.000286	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—urinary bladder cancer	3.33e-05	0.000282	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HPGDS—urinary bladder cancer	3.33e-05	0.000282	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.31e-05	0.00028	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.26e-05	0.000275	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—urinary bladder cancer	3.23e-05	0.000273	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.2e-05	0.00027	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.18e-05	0.000269	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RHOA—urinary bladder cancer	3.16e-05	0.000267	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.15e-05	0.000267	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.11e-05	0.000263	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.03e-05	0.000256	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.92e-05	0.000247	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.92e-05	0.000247	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.83e-05	0.000239	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NQO1—urinary bladder cancer	2.69e-05	0.000227	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—urinary bladder cancer	2.65e-05	0.000224	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.65e-05	0.000224	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.61e-05	0.00022	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.49e-05	0.00021	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—urinary bladder cancer	2.38e-05	0.000201	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.35e-05	0.000199	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—urinary bladder cancer	2.32e-05	0.000196	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.27e-05	0.000192	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.25e-05	0.00019	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—urinary bladder cancer	2.24e-05	0.000189	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.17e-05	0.000183	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—urinary bladder cancer	2.08e-05	0.000176	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—urinary bladder cancer	2.06e-05	0.000174	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOR1—urinary bladder cancer	2.06e-05	0.000174	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPX1—urinary bladder cancer	1.97e-05	0.000167	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000166	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.94e-05	0.000164	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ERCC2—urinary bladder cancer	1.94e-05	0.000164	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—urinary bladder cancer	1.92e-05	0.000162	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.83e-05	0.000154	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—urinary bladder cancer	1.82e-05	0.000154	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000153	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000153	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.8e-05	0.000152	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.8e-05	0.000152	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.000148	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.73e-05	0.000146	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—urinary bladder cancer	1.7e-05	0.000144	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.000143	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—urinary bladder cancer	1.63e-05	0.000138	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000135	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—urinary bladder cancer	1.48e-05	0.000125	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.45e-05	0.000123	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CREBBP—urinary bladder cancer	1.42e-05	0.00012	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000105	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	0.000102	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—urinary bladder cancer	1.16e-05	9.81e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.12e-05	9.51e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	9.4e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	9.4e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.06e-05	9e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	8.84e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	8.6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—urinary bladder cancer	1.01e-05	8.56e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.83e-06	8.31e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—urinary bladder cancer	9.66e-06	8.16e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—urinary bladder cancer	8.87e-06	7.5e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—urinary bladder cancer	8.46e-06	7.15e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.97e-06	6.74e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.65e-06	6.47e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.27e-06	5.3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.47e-06	4.62e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.21e-06	4.41e-05	CbGpPWpGaD
